How EIS can change the economics of investing in innovative UK companies such as RocketPhone.ai.
EIS combines access to early-stage growth companies with UK tax incentives designed to compensate investors for accepting greater investment risk and lower liquidity. This guide examines the benefits, risks and potential outcomes objectively.
For educational purposes only. Tax treatment depends on individual circumstances and legislation may change. Capital is at risk.
A UK Government scheme intended to encourage private investment into qualifying smaller companies by offering tax incentives to eligible investors.
Investors generally need to hold qualifying shares for at least three years to retain certain reliefs. Both company and investor eligibility conditions apply, and continued qualification matters. Advance Assurance indicates HMRC’s view of a proposed share issue based on information supplied; it is not approval of the investment and does not guarantee an investor’s ultimate entitlement to relief.
Evaluate two layers separately: the quality of the company and the tax-adjusted economics for the investor.
Four reliefs may materially alter effective exposure and after-tax outcomes. None is automatic, and all depend on applicable rules and individual circumstances.
Qualifying investors may currently claim relief equal to 30% of the amount invested, subject to limits and sufficient UK income-tax liability.
Where qualification requirements are satisfied, gains on qualifying EIS shares may be exempt from Capital Gains Tax.
A qualifying loss may potentially be set against income or capital gains after accounting for income-tax relief already received.
Qualifying EIS shares may potentially qualify for Business Relief for inheritance-tax purposes once relevant ownership and other conditions have been satisfied.
Current rules, transitional provisions and future reforms should be verified before any investment or estate-planning decision.
The underlying investment remains risky. The tax treatment can make the investor’s economic payoff asymmetric.
Maximum capital at risk: £100
No EIS downside mitigation assumed.
Illustrative effective loss: £38.50
Assumes 30% initial relief, total failure and usable loss relief at an illustrative 45% rate.
The investor participates in the full equity upside. Gains on qualifying shares may potentially be free of CGT.
Initial income-tax relief and potential loss relief may materially reduce the effective economic loss.
Tax relief reduces downside. It does not reduce the probability that the company fails.
Early-stage outcomes range from complete loss to rare outlier returns. Individual investments are highly unpredictable; portfolio construction matters.
Company exit value
At a 45% illustrative income-tax rate, initial and loss relief could reduce a £100,000 economic loss to £38,500. Tax conditions apply.
Company proceeds · 1× gross
The commercial investment has not grown, but retained £30,000 initial relief could create a positive tax-adjusted result.
Exit proceeds · 3× gross
£200,000 company gain; potential CGT exemption plus initial relief. Tax-adjusted proceeds relative to £70,000 effective exposure: 4.29×.
Exit proceeds · 10× gross
Outliers can transform portfolio results. Returns of this magnitude are uncommon and should not form the base case.
Returns are rarely evenly distributed. A small number of companies may generate a substantial proportion of a portfolio’s total value.
Ten investments of £10,000. Three fail; two return capital; three return 2×; one returns 4×; one returns 8×.
Gross value by company. The 8× outcome accounts for 40% of portfolio value.
Diversification does not guarantee success. It increases the chance of participating in the small number of companies that may drive returns.
EIS is best considered as private growth capital: potentially complementary to core assets, not a replacement for them.
| Asset class | Return potential | Liquidity | Capital risk | Tax features | Typical horizon |
|---|---|---|---|---|---|
| EIS | High / highly dispersed | Very low | Very high | Income-tax, qualifying gain, loss and potential IHT treatment | 5–10+ years |
| Listed equities | Growth and income | Generally high | Market risk | ISA/pension wrappers may apply | 5+ years |
| Venture capital | High / power-law | Very low | Very high | Structure-dependent | 7–12+ years |
| Private equity | Growth / value creation | Low | High | Structure-dependent | 5–10 years |
| Property | Income and appreciation | Low | Market, leverage, concentration | Tax varies by ownership and use | Long term |
| Cash / bonds | Low to moderate | High to moderate | Inflation, credit, rate risk | Wrapper-dependent | Short to long |
EIS may represent part of an alternative allocation depending on risk tolerance, tax position, liquidity needs, age, wealth, experience and time horizon. No universal percentage is appropriate.
For investors with UK income-tax liability, sufficient liquid assets elsewhere, comfort with long holding periods, and a desire for exposure to UK growth businesses.
Where capital access is important, losses cannot be tolerated, tax liability is insufficient, concentration would be excessive, or tax relief is the principal thesis.
Three years is generally a minimum qualifying holding period for certain reliefs—not a promise of commercial liquidity.
Assume the investment remains illiquid for longer than expected.
Tax treatment is secondary to company selection, entry valuation and the capacity to create durable enterprise value.
Large addressable market, real customer need, defensible advantage, scalable revenue and attractive unit economics.
Strong management, sound governance, credible milestones, capital efficiency and ability to raise follow-on capital.
Realistic valuation, identifiable strategic acquirers, exit optionality and a credible route from today’s value to the required outcome.
A great company bought at an excessive valuation can still produce a mediocre investment return.
Private companies frequently issue more shares. Investors who do not participate may own a smaller percentage.
Dilution is not necessarily destructive when new capital creates substantially more enterprise value.
2× over 3 years
2× over 7 years
3× over 5 years
5× over 8 years
Illustrative compound annual growth rates before fees and tax. A multiple without a period is an incomplete measure.
A disciplined investment memo should answer commercial, financial, governance and qualification questions—not simply repeat management’s forecast.
What problem is solved? How large is the addressable market? What independent evidence supports product-market fit? What makes the advantage defensible?
What are current revenues, growth rates and gross margins? How concentrated is the customer base? Is revenue contracted, recurring or transactional?
How much cash is available? What is monthly net burn? How long is runway, and what milestones must be met before the next raise?
At what pre- and post-money valuation am I investing? What exit value and dilution assumptions are required to achieve 3× or 5×?
How credible is the team? What has it delivered? Which assumptions could prevent success? Is key-person dependence excessive?
How much additional capital is likely? On what plausible terms? Can existing investors participate? How does the cap table change?
What shareholder protections exist? Who are plausible acquirers? What evidence supports their interest? What alternative paths to liquidity exist?
Has Advance Assurance been obtained where relevant? What conditions must continue to be met? What happens economically if qualification or relief is lost?
Explore how company performance, time and selected tax assumptions interact. Commercial and tax-adjusted returns are shown separately.
Illustrative only—not personalised investment or tax advice.
*CGT saving uses a clearly illustrative 24% rate solely to demonstrate mechanics. Actual tax depends on individual circumstances and rules at the relevant time. Loss relief is simplified and assumes the selected share of capital is lost; real claims require professional calculation.
These examples demonstrate mechanics. They are not expected returns.
£50,000 becomes £250,000 after seven years. Potential initial relief: £15,000. Commercial gain: £200,000. Gross annualised return: approximately 25.8% before fees and tax.
In a £100,000 portfolio, failures and modest outcomes may coexist with one 8–10× company that contributes a substantial share of value.
£250,000 deployed across businesses and several years may diversify industries, economic cycles, maturity and potential exit timing.
The benefits deserve no more emphasis than the risks. An investor should be financially capable of losing the capital invested.
Invest for the underlying company—not simply the tax relief.
Assume capital remains illiquid well beyond three years.
Spread exposure where practical, across companies and vintages.
Model failed investments as part of the distribution, not an anomaly.
Look for outcomes where winners can outweigh unsuccessful holdings.
Not to eliminate risk, but to construct a portfolio in which potential rewards appropriately compensate the investor for accepting it.